Dr. Lisa Larkin

Dr. Larkin is passionate about raising the standard of care for women and advancing evidence-based women’s healthcare. Considered a national expert in menopause management, sexual medicine, and breast cancer risk assessment and prevention. Dr. Larkin is committed to advancing evidence-based medicine. She is a devoted clinician educator and lectures frequently at physician CME programs and educational events on women’s health topics.  Dr. Larkin is also well-published in the area of menopause and sexual medicine. She participated in the development of and is co-author of several recent important manuscripts, including the ISSWSH consensus guidelines on the identification and evaluation of sexual concerns in women (Mayo Clinic Proceedings 2019), the ISSWSH process of care for the management of hypoactive sexual desire disorder (Mayo Clinic Proceedings 2018), and the NAMS/ISSWSH consensus recommendations for the management of genitourinary syndrome of menopause in women with or at high risk of breast cancer (Menopause 2018). Dr. Larkin also devotes considerable time to women’s health consumer education and is a frequent community lecturer and expert media resource on various women’s health topics. She is also committed to women’s health advocacy. She spoke to the FDA in 2015 as part of a group advocating for the approval of flibanserin, the first FDA-approved medication for female sexual dysfunction, and again in 2016 as part of a group advocating for the label change of local vaginal estrogen. Additionally, she serves as an advisor to several pharmaceutical, consumer product and device companies.

Named one of Cincinnati’s “Top Docs” every year since 1991 (by Cincinnati Magazine) and winner of the 2019 Health Care Entrepreneur Hero Award by the Cincinnati Business Courier, she is recognized by her peers, patients, members of the community, and the media as an exceptional provider, advocate, educator, innovator, and health care disruptor.